Cardiology

Medicine & Life Sciences

1. Heart 100%
2. Heart Failure 91%
3. Stem Cells 87%
4. Endothelial Cells 78%
5. Cardiovascular Diseases 73%
6. Blood Vessels 73%
7. Exosomes 69%
8. Myocardial Infarction 69%
9. Cardiac Myocytes 67%
10. Atrial Fibrillation 65%
11. MicroRNAs 62%
12. Adipose Tissue 57%
13. Smooth Muscle Myocytes 55%
14. Global Burden of Disease 55%
15. Cardiomyopathies 51%
16. Therapeutics 50%
17. Mesenchymal Stem Cells 50%
18. Neoplasms 49%
19. Coronary Vessels 49%
20. Atherosclerosis 48%
21. Mortality 48%
22. Inflammation 47%
23. 14,15-epoxy-5,8,11-eicosatrienoic acid 46%
24. Induced Pluripotent Stem Cells 44%
25. Reactive Oxygen Species 41%
26. Vascular Smooth Muscle 40%
27. Clustered Regularly Interspaced Short Palindromic Repeats 39%
28. Vascular Diseases 39%
29. Abdominal Aortic Aneurysm 39%
30. Ischemia 38%
31. Adenosine Kinase 37%
32. Coronary Artery Disease 36%
33. Copper Transport Proteins 36%
34. Thrombosis 35%
35. Hypertension 35%
36. Myocardial Perfusion Imaging 34%
37. Apoptosis 33%
38. 14,15-dihydroxyeicosatrienoic acid 32%
39. Genes 31%
40. Myocardium 31%
41. Cell- and Tissue-Based Therapy 31%
42. Swine 30%
43. NADPH Oxidases 30%
44. Adipocytes 29%
45. Acids 29%
46. Proteins 27%
47. Myocardial Ischemia 27%
48. Cardiotoxicity 27%
49. Obesity 27%
50. Blood Pressure 27%
51. Wounds and Injuries 26%
52. Hospitalization 26%
53. Smooth Muscle 25%
54. Chimeric Antigen Receptors 25%
55. Safety 25%
56. Dystrophin 25%
57. Coronavirus 25%
58. Stroke 25%
59. Vascular Endothelial Growth Factor A 24%
60. 11,12-epoxy-5,8,14-eicosatrienoic acid 24%
61. Coronary Atherectomy 24%
62. Oxidative Stress 24%
63. Cardiac Arrhythmias 23%
64. Pandemics 23%
65. In Vitro Techniques 23%
66. Adenosine 23%
67. Muscle Cells 23%
68. Perfusion 23%
69. Infarction 23%
70. Aortic Valve 22%
71. Carvedilol 22%
72. Surgical Instruments 22%
73. Aorta 22%
74. Angiotensin II 22%
75. Heart Diseases 22%
76. Artificial Intelligence 22%
77. Population 22%
78. Oxidation-Reduction 22%
79. Long Noncoding RNA 22%
80. Peripartum Period 21%
81. Glycolysis 21%
82. Transplantation 21%
83. Exercise 21%
84. Incidence 21%
85. Technology 21%
86. Epoxide Hydrolases 21%
87. Percutaneous Coronary Intervention 21%
88. Cell Survival 20%
89. persenone A 20%
90. High Fat Diet 20%
91. Aortic Aneurysm 20%
92. Magnetic Resonance Spectroscopy 19%
93. 20-hydroxy-5,8,11,14-eicosatetraenoic acid 19%
94. Transesophageal Echocardiography 19%
95. Heart-Assist Devices 19%
96. Epigenomics 19%
97. Amyloidosis 19%
98. Antioxidants 19%
99. Registries 19%
100. Cell Proliferation 18%